Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.
Non-alcoholic Fatty Liver Disease Study Group; Lonardo A, Bellentani S, Argo CK, Ballestri S, Byrne CD, Caldwell SH, Cortez-Pinto H, Grieco A, Machado MV, Miele L, Targher G. Non-alcoholic Fatty Liver Disease Study Group, et al. Among authors: bellentani s. Dig Liver Dis. 2015 Dec;47(12):997-1006. doi: 10.1016/j.dld.2015.08.004. Epub 2015 Aug 14. Dig Liver Dis. 2015. PMID: 26454786 Review.
A "systems medicine" approach to the study of non-alcoholic fatty liver disease.
Petta S, Valenti L, Bugianesi E, Targher G, Bellentani S, Bonino F; Special Interest Group on Personalised Hepatology of the Italian Association for the Study of the Liver (AISF); Special Interest Group on Personalised Hepatology of Italian Association for Study of Liver AISF. Petta S, et al. Among authors: bellentani s. Dig Liver Dis. 2016 Mar;48(3):333-42. doi: 10.1016/j.dld.2015.10.027. Epub 2015 Nov 14. Dig Liver Dis. 2016. PMID: 26698409 Free article. Review.
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030.
Goossens N, Bellentani S, Cerny A, Dufour JF, Jornayvaz FR, Mertens J, Moriggia A, Muellhaupt B, Negro F, Razavi H, Semela D, Estes C. Goossens N, et al. Among authors: bellentani s. Swiss Med Wkly. 2019 Dec 17;149:w20152. doi: 10.4414/smw.2019.20152. eCollection 2019 Dec 16. Swiss Med Wkly. 2019. PMID: 31846507 Free article.
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study.
Foschi FG, Bedogni G, Domenicali M, Giacomoni P, Dall'Aglio AC, Dazzani F, Lanzi A, Conti F, Savini S, Saini G, Bernardi M, Andreone P, Gastaldelli A, Casadei Gardini A, Tiribelli C, Bellentani S, Stefanini GF. Foschi FG, et al. Among authors: bellentani s. BMC Gastroenterol. 2018 Nov 28;18(1):177. doi: 10.1186/s12876-018-0906-8. BMC Gastroenterol. 2018. PMID: 30486798 Free PMC article.
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, Colombo M, Craxi A, Crespo J, Day CP, Eguchi Y, Geier A, Kondili LA, Kroy DC, Lazarus JV, Loomba R, Manns MP, Marchesini G, Nakajima A, Negro F, Petta S, Ratziu V, Romero-Gomez M, Sanyal A, Schattenberg JM, Tacke F, Tanaka J, Trautwein C, Wei L, Zeuzem S, Razavi H. Estes C, et al. Among authors: bellentani s. J Hepatol. 2018 Oct;69(4):896-904. doi: 10.1016/j.jhep.2018.05.036. Epub 2018 Jun 8. J Hepatol. 2018. PMID: 29886156 Free article.
Epidemiology of non-alcoholic fatty liver disease.
Bellentani S, Scaglioni F, Marino M, Bedogni G. Bellentani S, et al. Dig Dis. 2010;28(1):155-61. doi: 10.1159/000282080. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460905
104 results